« Previous
Next »
Molecular Oncology
Volume 1, Issue 1
, Pages
14-18
, June 2007
Europe combating cancer: The European Union's commitment to cancer research in the 6th Framework Programme
-
Spending on cancer research under FP6. (a) Total spending (€485 million) of the European Commission in FP6 (2002–2006) according to the five different areas described in the text (in million Euro). (b
Spending on cancer research under FP6. (a) Total spending (€485 million) of the European Commission in FP6 (2002–2006) according to the five different areas described in the text (in million Euro). (b) Total spending (in million Euro) according to various subgroups in each of the five areas. The same colour codes apply in (a) and (b).
-
Relation of different cancers funded in FP6 projects and their incidence in Europe. Numbers of projects funded on particular cancer sites in relation to 5-year median survival rates and incidence in ERelation of different cancers funded in FP6 projects and their incidence in Europe. Numbers of projects funded on particular cancer sites in relation to 5-year median survival rates and incidence in Europe (). Grey circle shows only cancer type currently not covered (testicular cancer) in FP6. Numbers in blue circles indicate the number of projects dealing with a particular cancer type.
-
FP6 projects on molecular targets. Numbers of projects funded on molecular targets according to the six hallmarks of cancer (Hanahan and Weinberg, 2000). Forty-six out of the 108 total cancer researchFP6 projects on molecular targets. Numbers of projects funded on molecular targets according to the six hallmarks of cancer (Hanahan and Weinberg, 2000). Forty-six out of the 108 total cancer research-related projects in FP6 fall in these six categories.
PII: S1574-7891(07)00003-8
doi: 10.1016/j.molonc.2007.01.002
© 2007 Federation of European Biochemical Societies. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Molecular Oncology
Volume 1, Issue 1
, Pages
14-18
, June 2007

